Disclaimer Copyright 2007 Eigenbrodt / Mazurek Webdesign and Webserver by onSite
Tumor M2-PK:
a tool for metabolic profiling of pancreatic cancer
Comparison of sensitivities of Tumor M2-PK, CEA, CA19-9 and CA 72.4 in pancreatic tumors
nm = non metastasized; m = metastasized; t = total n.d.a. = no data available
Sensitivities for combination of Tumor M2-PK with classical tumor markers
Schulze, 2000:Tumor M2-PK + Ca 19-9: 96 %
Ventrucci et al., 2001: Tumor M2-PK + CA 19-9: 96 %
Tumor M2-PK concentrations were measured with a sandwich ELISA from ScheBo • Biotech AG, Giessen, Germany.
CEA, CA-19-9 and CA 72-4 were determined using, Cobras Core II from Roche Diagnostics, Mannheim, enzymun Test-ES 600 Immunology Multianalyzer as well as tests from Sorin Diagnostics, Saluggia.
